| All Releases |
|---|
 |
Volcano Announces OCT Activities at EuroPCR 2009
May 19, 2009
|
22.8 KB
|
| |
SAN DIEGO and BARCELONA, Spain, May 19, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis of coronary and peripheral artery disease, today highlights its technology leadership position in the emerging field of Optical Coherenc...
|
|
|
Volcano Announces Worldwide Exclusive Distribution Agreement With Lumen Biomedical for Xtract(TM) Thrombus Aspiration Catheter
May 18, 2009
|
23.7 KB
|
| |
SAN DIEGO, May 18, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today announced an exclusive worldwide distribution agreement to initiate the formal launch of the X...
|
|
|
Volcano Corporation Presentation at JMP Conference to be Webcast
May 12, 2009
|
19.6 KB
|
| |
SAN DIEGO, May 12, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the Eighth Annual JMP Securities Research Conference on ...
|
|
|
Volcano Corporation Presentation at Bank of America/Merrill Lynch Conference to be Webcast
May 6, 2009
|
19.5 KB
|
| |
SAN DIEGO, May 6, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the Bank of America and Merrill Lynch 2009 Health Care Co...
|
|
|
Volcano Reports First Quarter Revenues of $49.0 Million; IVUS and FM Businesses Grew 24 Percent
May 5, 2009
|
30.7 KB
|
| |
SAN DIEGO, May 5, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today reported revenues of $49.0 million for the first quarter of fiscal 2009.
The results for the q...
|
|
|
Volcano Corporation Schedules First Quarter Conference Call, Webcast
Apr 27, 2009
|
19.4 KB
|
| |
SAN DIEGO, April 27, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today announced that it will report its operating results for the first quarter of fiscal 2009 on ...
|
|
|
Volcano Announces the Availability of Integrated Fractional Flow Reserve Technology on All Major Cardiovascular X-ray Angiography Systems
Apr 1, 2009
|
20.7 KB
|
| |
SAN DIEGO, Mar. 27, 2009 - Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today announced the availability of its integrated Fractional Flow Reserve (FFR) technology on all major cardiovascular x-ray systems.
I...
|
|
|
Volcano Announces Schedule of Events at the ACC 2009, Integration into Indec and Medis Software Platforms
Mar 27, 2009
|
20.7 KB
|
| |
SAN DIEGO, Mar. 26, 2009 -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today announced its presence at the 58th Annual Scientific Sessions of the American College of Cardiology (ACC) conference in Orlando, FL, to b...
|
|
|
Volcano Corporation Announces Webcast of February 25th Analyst Day
Feb 20, 2009
|
19.2 KB
|
| |
SAN DIEGO, Feb 20, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, will hold its 2009 Analyst Day on Wednesday, February 25, at the NASDAQ MarketSite in New York City....
|
|
|
Volcano Reports Full Year Revenues Increase 31 Percent
Feb 17, 2009
|
36.1 KB
|
| |
SAN DIEGO, Feb 17, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today reported that revenues for the full year 2008 increased 31 percent over full year 2007 and tha...
|
|
|
Volcano Corporation Presentation at Roth Capital Partners Conference to Be Webcast
Feb 12, 2009
|
19.4 KB
|
| |
SAN DIEGO, Feb 12, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation
(Nasdaq: VOLC), a leader in the development, manufacturing and sales of
products for the diagnosis and treatment of coronary and peripheral artery
disease, said today that it will be participating in the Roth Capital Partners
21st Annual Growth Stock C...
|
|
|
Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
Feb 6, 2009
|
19.4 KB
|
| |
SAN DIEGO, Feb 06, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation
(Nasdaq: VOLC), a leader in the development, manufacturing and sales of
products for the diagnosis and treatment of coronary and peripheral artery
disease, today announced that it will report is operating results for the
fourth quarter and all of fisca...
|
|
|
Volcano Highlights Commitment, Market Acceptance of FFR Product Line
Jan 20, 2009
|
22.7 KB
|
| |
SAN DIEGO, Jan 20, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation
(Nasdaq: VOLC), a leader in the development, manufacturing and sales of
products for the diagnosis and treatment of coronary and peripheral artery
disease, today commented on the increased demand for their FFR and IVUS
capable consoles, as well as thei...
|
|
|
Volcano Announces Closing of Axsun Technologies Acquisition
Jan 7, 2009
|
19.8 KB
|
| |
SAN DIEGO, Jan 07, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation
(Nasdaq: VOLC), a leader in the development, manufacturing and sales of
products for the diagnosis and treatment of coronary and peripheral artery
disease, said today that it has closed its previously announced acquisition of
Axsun Technologies, Inc.
...
|
|
|
Volcano Corporation Presentation at J.P. Morgan Conference to be Webcast
Jan 6, 2009
|
19.5 KB
|
| |
SAN DIEGO, Jan 06, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation
(Nasdaq: VOLC), a leader in the development, manufacturing and sales of
products for the diagnosis and treatment of coronary and peripheral artery
disease, said today that it will be participating in the 27th Annual J.P.
Morgan Healthcare Conference on...
|
|
|
Reminder: Volcano Corporation Schedules Conference Call, Webcast to Discuss Axsun Transaction
Jan 5, 2009
|
19.3 KB
|
| |
SAN DIEGO, Jan 05, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation
(Nasdaq: VOLC), a leader in the development, manufacturing and sales of
products for the diagnosis and treatment of coronary and peripheral artery
disease, will conduct a conference call and webcast Tuesday, January 6, to
discuss its acquisition of Axs...
|
|
|
Volcano Corporation Presentation at Piper Jaffray Conference to Be Webcast
Nov 24, 2008
|
19.9 KB
|
| |
SAN DIEGO, Nov 24, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the 20th Annual Piper Jaffray Health Care Conference on ...
|
|
|
Volcano Reports 40 Percent Growth in Quarterly Revenues
Nov 5, 2008
|
35.7 KB
|
| |
SAN DIEGO, Calif., Nov 05, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today reported that revenues for the third quarter of 2008 increased 40 percent over those i...
|
|
|
Volcano Corporation Schedules Third Quarter Conference Call, Webcast
Oct 28, 2008
|
18.8 KB
|
| |
SAN DIEGO, Oct 28, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today announced that it will report its operating results for the third quarter and first nine month...
|
|
|
Volcano Corporation Announces Launch of PrimeWire(TM) Pressure Guidewire and s5-FFR Option for Existing Fleet of s5 IVUS Consoles
Oct 15, 2008
|
23.8 KB
|
| |
WASHINGTON, Oct 15, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC) today announced the launch of the PrimeWire(TM) Pressure Guidewire, and the s5-FFR Option for its existing installed base of s5 and s5i imaging consoles in the U.S. The PrimeWire is Volcano's newest pressure guidewire, capable of measuring ...
|
|
|
